Macquarie Group LTD Delcath Systems, Inc. Transaction History
Macquarie Group LTD
- $83.5 Billion
- Q3 2025
A detailed history of Macquarie Group LTD transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,393 shares of DCTH stock, worth $21,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,393Holding current value
$21,369% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
130Shares Held
13MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...